The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector

PharmaDeals Ltd
March 19, 2012
202 Pages - SKU: PHV3815907

The 2012 Report presents:

  • Major new case studies
  • Full, new data and analysis based on data from the premier agreements database, PharmaDeals® v4, and other sources
  • Topics including Royalties and Deal Structures, Sales Milestones, Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication.
  • Data and analysis of a recent major survey undertaken by PharmaVentures about royalties and changes in deal making over the last 5 years
  • A glossary, and a wealth of figures and tables
The Report updates previous editions with a review of methods for calculating royalties, including topics such as research and development costs, benchmarking, transfer pricing, the basics of eNPV and NPV calculation, cash flows, relevant costs, risk and cash burn.




More Pricing reports by PharmaDeals Ltd

The Royalty Rate Report 2014: A comprehensive assessment of valuation in the pharmaceutical sector by PharmaDeals Ltd
The Royalty Rate Report 2014: A comprehensive assessment of valuation in the pharmaceutical sector Key Benefits First hand insight on royalty rates ...
See all reports like this >>

 

SELECT A LICENSE

    Single User Annual Subscription   USD 8,005  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!